Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural integration in hypoxia-inducible factors
Dalei Wu, Nalini Potluri, Jingping Lu, et al.
Nature (2015) Vol. 524, Iss. 7565, pp. 303-308
Closed Access | Times Cited: 289

Showing 1-25 of 289 citing articles:

Transcriptional architecture of the mammalian circadian clock
Joseph S. Takahashi
Nature Reviews Genetics (2016) Vol. 18, Iss. 3, pp. 164-179
Open Access | Times Cited: 2157
Targeting renal cell carcinoma with a HIF-2 antagonist
Wenfang Chen, Haley Hill, Alana Christie, et al.
Nature (2016) Vol. 539, Iss. 7627, pp. 112-117
Open Access | Times Cited: 612
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 539
The ever-expanding role of HIF in tumour and stromal biology
Edward L. LaGory, Amato J. Giaccia
Nature Cell Biology (2016) Vol. 18, Iss. 4, pp. 356-365
Open Access | Times Cited: 386
Oxygen availability and metabolic adaptations
Michael S. Nakazawa, Brian Keith, M. Celeste Simon
Nature reviews. Cancer (2016) Vol. 16, Iss. 10, pp. 663-673
Open Access | Times Cited: 373
Targeting the HIF2–VEGF axis in renal cell carcinoma
Toni K. Choueiri, William G. Kaelin
Nature Medicine (2020) Vol. 26, Iss. 10, pp. 1519-1530
Closed Access | Times Cited: 359
Hypoxia-inducible factors: cancer progression and clinical translation
Elizabeth E. Wicks, Gregg L. Semenza
Journal of Clinical Investigation (2022) Vol. 132, Iss. 11
Open Access | Times Cited: 341
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Eli M. Wallace, James P. Rizzi, Guangzhou Han, et al.
Cancer Research (2016) Vol. 76, Iss. 18, pp. 5491-5500
Open Access | Times Cited: 274
Mechanisms of hypoxia signalling: new implications for nephrology
Johannes Schödel, Peter J. Ratcliffe
Nature Reviews Nephrology (2019) Vol. 15, Iss. 10, pp. 641-659
Closed Access | Times Cited: 267
Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine
Rashi Singhal, Yatrik M. Shah
Journal of Biological Chemistry (2020) Vol. 295, Iss. 30, pp. 10493-10505
Open Access | Times Cited: 255
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Pharmacologic Targeting of Hypoxia-Inducible Factors
Gregg L. Semenza
The Annual Review of Pharmacology and Toxicology (2019) Vol. 59, Iss. 1, pp. 379-403
Open Access | Times Cited: 247
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
Mircea Ivan, William G. Kaelin
Molecular Cell (2017) Vol. 66, Iss. 6, pp. 772-779
Open Access | Times Cited: 239
Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition
Julianty Frost, Carles Galdeano, Pedro Soares, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 200
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
Guanzhong Qiu, Mingzhu Jin, Jinxiang Dai, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 8, pp. 669-686
Open Access | Times Cited: 196
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
Rouven Hoefflin, Sabine Harlander, Silvia Schäfer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 194
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
Debangshu Samanta, Gregg L. Semenza
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 1, pp. 15-22
Closed Access | Times Cited: 169
HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma
Kevin D. Courtney, Yuanqing Ma, Alberto Diaz de Leon, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 4, pp. 793-803
Open Access | Times Cited: 151
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Yongchao Zhao, Weidong Xiong, Chaofu Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 99
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
Xiaoyi Yuan, Wei Ruan, Bentley J. Bobrow, et al.
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 3, pp. 175-200
Closed Access | Times Cited: 65
Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer
Jiayi Zhang, Mengqin Yao, Siyu Xia, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex
Xiaotong Diao, Qinghong Shang, Mengqi Guo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Hypoxia-inducible factors: a central link between inflammation and cancer
Daniel Triner, Yatrik M. Shah
Journal of Clinical Investigation (2016) Vol. 126, Iss. 10, pp. 3689-3698
Open Access | Times Cited: 168
Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells
Ludovica Marinelli, Camille Martin‐Gallausiaux, Jean‐Marie Bourhis, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 138
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
Mun Chiang Chan, James P. Holt‐Martyn, Christopher J. Schofield, et al.
Molecular Aspects of Medicine (2016) Vol. 47-48, pp. 54-75
Open Access | Times Cited: 120
Page 1 - Next Page

Scroll to top